998
F. Wang et al.
J=8.8, 1.6 Hz, 1H),7.37 (dd, J=8.8, 1.6 Hz, 1H), 6.96 (dd,
J=8.8, 4.0 Hz, 1H), 2.95 (s,12H, N-CH3) ppm; 13C NMR
(100 MHz, CDCl3): δ = 161.75, 148.01, 128.84, 128.56,
126.39, 40.56, 38.59 ppm; HRMS (ESI): m/z calculated for
C9H16N3O2S2 ([M+H]+) 262.0678, found 262.0686.
General procedure for preparing
N‑sulfonylguanidines
A solution of 153.3 mg phosphoryl chloride (1.0 mmol, 1.0
equiv.) in 2.0 cm3 of DCM was added dropwise to a solution
of the appropriate urea 2 (1.2 mmol, 1.2 equiv.) in 3.0 cm3
of DCM at room temperature and stirred for 15 min, and
then the sulfonamide 1 (1.0 mmol, 1.0 equiv.) was added
in one portion and 0.3 g TEA (3.0 mmol, 3.0 equiv) was
added dropwise to the reaction mixture and stirred at room
temperature for 1 h. The reaction mixture was poured into
10 cm3 of water and extracted with 30 cm3 of DCM (3 times)
and the combined organic layer was dried over anhydrous
MgSO4 and fltered, the solvent was removed and the crude
reaction mixture was purifed by column chromatography on
silica gel column (ethyl acetate/petroleum ether) chromatog-
raphy to aford the desired products.
N‑[Bis(dimethylamino)methylene]‑1‑phenylmethanesul‑
fonamide (3j, C12H20N3O2S) White solid; Rf = 0.36 (EA:
PE=8:1); m.p.:104–105 °C; 1H NMR (400 MHz, CDCl3):
δ=7.48 (d, J=6.4 Hz, 2H), 7.35–7.29 (m, 3H), 4.31 (s, 2H),
2.86 (s, 12H) ppm; 13C NMR (100 MHz, CDCl3): δ=162.07,
131.27, 130.75, 128.34, 61.98, 40.44, 38.59 ppm; HRMS
(ESI): m/z calculated for C12H20N3O2S ([M+H]+) 270.1271,
found 270.1276.
N‑[Bis(dimethylamino)methylene]methanesulfonamide
(3k, C6H16N3O2S) White solid; Rf = 0.26 (EA: PE = 8:1);
1
m.p.: 109–110 °C; H NMR (400 MHz, CDCl3): δ = 2.99
All new compounds (3d–3e, 3h–3n, and 5a–5c) were
characterized using 1H and 13C NMR and HRMS analysis.
The known compounds (3a–3c, 3f, 3g, 3o, and 3p) have sat-
isfactory melting points and spectral data which are identical
with those reported in the literature [35–38].
(s, 3H), 2.95 (s, 12H) ppm; 13C NMR (100 MHz, CDCl3):
δ=161.94, 44.42, 40.37 ppm; HRMS (ESI): m/z calculated
for C6H16N3O2S ([M+H]+) 194.0958, found 194.0965.
N‑[Bis(dimethylamino)methylene]‑2‑methylpropane‑2‑sul‑
fonamide (3l, C9H22N3O2S) White solid; Rf = 0.24 (EA:
N‑[Bis(dimethylamino)methylene]‑4‑(tert‑butyl)benzene‑
sulfonamide (3d, C15H26N3O2S) White solid; Rf =0.40 (EA:
PE=8:1); m.p.: 108–109 °C; 1H NMR (400 MHz, CDCl3):
δ=7.85 (d, J=8.8 Hz, 2H), 7.43 (d, J=8.4 Hz, 2H), 2.93
(s, 12H), 1.31 (s, 9H) ppm; 13C NMR (100 MHz, CDCl3):
δ = 161.89, 154.06, 142.94, 125.37, 125.32, 40.50, 34.86,
31.17 ppm; HRMS (ESI): m/z calculated for C15H26N3O2S
([M+H]+) 312.1740, found 312.1747.
1
PE = 5:1); m.p.: 79–80 °C; H NMR (400 MHz, CDCl3):
δ = 2.95 (s, 12H),1.43 (s, 9H) ppm; 13C NMR (100 MHz,
CDCl3): δ=162.57, 58.89, 40.53, 24.78 ppm; HRMS (ESI):
m/z calculated for C9H22N3O2S ([M+H]+) 236.1427, found
236.1434.
N‑[Bis(diethylamino)methylene]‑4‑methylbenzenesul‑
fonamide (3m, C16H28N3O2S) White solid; Rf = 0.54 (EA:
PE=3:1); m.p.: 107–109 °C; 1H NMR (400 MHz, CDCl3):
δ=7.80 (d, J=8.4 Hz, 2H), 7.21 (d, J =8.0 Hz, 2H), 3.31
(q, J=7.2 Hz, 8H), 2.37 (s, 3H), 1.11 (t, J =7.2 Hz, 12H)
ppm; 13C NMR (100 MHz, CDCl3): δ = 161.10, 143.07,
140.80, 128.86, 125.62, 43.98, 21.36, 13.09 ppm; HRMS
(ESI): m/z calculated for C16H28N3O2S ([M+H]+) 326.1897,
found 326.1903.
N‑[Bis(dimethylamino)methylene]‑4‑chlorobenzenesul‑
fonamide (3e, C11H17ClN3O2S) White solid; Rf = 0.42 (EA:
PE=8:1); m.p.: 103–104 °C; 1H NMR (400 MHz, CDCl3):
δ=7.87 (d, J=8.4 Hz, 2H), 7.40 (d, J=8.4 Hz, 2H), 2.93
(s, 12H) ppm; 13C NMR (100 MHz, CDCl3): δ = 161.83,
144.40, 136.83, 128.61, 127.16, 40.53, 38.59 ppm; HRMS
(ESI): m/z calculated for C11H17ClN3O2S ([M + H]+)
290.0725, found 290.0732.
N‑[Bis(dibutylamino)methylene]‑4‑methylbenzenesul‑
fonamide (3n, C24H44N3O2S) White solid; Rf = 0.45 (EA:
N‑[Bis(dimethylamino)methylene]‑5‑methylpyridine‑2‑sul‑
fonamide (3h, C11H19N4O2S) White solid; Rf = 0.21 (EA:
PE=8:1); m.p.: 161–162 °C; 1H NMR (400 MHz, CDCl3):
δ=8.45 (s, 1H), 7.97 (d, J=8 Hz, 1H), 7.62 (d, J=9.2 Hz,
1H), 2.98 (s, 12H), 2.38 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3): δ = 162.23, 158.45, 149.61, 137.91, 135.61,
120.63, 40.69, 18.41 ppm; HRMS (ESI): m/z calculated for
C11H19N4O2S ([M+H]+) 271.1223, found 271.1229.
1
PE = 1:1); m.p.: 59–60 °C; H NMR (400 MHz, CDCl3):
δ=7.78 (d, J=8.4 Hz, 2H), 7.20 (d, J =8.4 Hz, 2H), 3.23
(t, J=7.8 Hz, 8H), 2.36 (s, 3H), 1.49–1.41 (m, 8H), 1.249
(m, 8H), 0.87 (t, J=7.2 Hz, 12H) ppm; 13C NMR (100 MHz,
CDCl3): δ=161.25, 142.99, 140.72, 128.80, 125.73, 49.71,
29.95, 21.31, 20.10, 13.75 ppm; HRMS (ESI): m/z calculated
for C24H44N3O2S ([M+H]+) 438.3149, found 438.3157.
Phenyl [bis(dimethylamino)methylene]sulfamate (5a,
C11H18N3O3S) White solid; Rf =0.30 (EA: PE=3:1); m.p.:
96–97 °C; 1H NMR (400 MHz, CDCl3): δ=7.40–7.38 (m,
N‑[Bis(dimethylamino)methylene]thiophene‑2‑sulfonamide
(3i, C9H16N3O2S) White solid; Rf =0.30 (EA: PE=8:1); m.p.:
1
106–107 °C; H NMR (400 MHz, CDCl3): δ = 7.54 (dd,
1 3